mead cohen berger shevtsova garfinkle michta grygiel blankenhorn
This is your free article this month. A quality publication is not cheap to produce.
Subscribe today and support The American Interest—only $2.99/month!
Already a subscriber? Log in to make this banner go away.
Appeared in: Volume 10, Number 2
Published on: October 17, 2014
To Your Health
Nudging the FDA

There’s a better way between the contending libertarian and paternalist approaches to regulating drugs.

W. Nicholson Price II is assistant professor at the University of New Hampshire School of Law, where he writes on innovation and regulation in the life sciences. I. Glenn Cohen is professor, Harvard Law School, and director, Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics. His next book is New and Enduring Challenges for FDA: Selected Essays on the Future of the Agency and its Regulation of Drugs and New Technologies (co-edited with Holly Fernandez Lynch), forthcoming in 2015 from Columbia University Press.
show comments
© The American Interest LLC 2005-2016 About Us Masthead Submissions Advertise Customer Service